Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif containing 41 (TRIM41)
- Target
- TRIM41
- Molecular classification
- Enzyme (E3 ubiquitin ligase), Tripartite motif-containing (TRIM) protein family, Zinc finger protein (contains a RING domain)
01
Overview
Tripartite motif containing 41 (TRIM41) is an E3 ubiquitin-protein ligase belonging to the tripartite motif-containing (TRIM) family. It contains a RING zinc finger, B-box domains, and a coiled-coil region. TRIM41 is expressed constitutively in many cell types, including immune and germ cells, and is central to the host antiviral response by targeting viral nucleoproteins for ubiquitination and proteasomal degradation, thereby limiting viral replication. In addition, TRIM41 regulates chromosome axis protein dynamics, which is essential for proper synapsis and fertility in male meiosis. Dysregulation or deficiency of TRIM41 impairs innate immune response and can lead to increased viral susceptibility or fertility disorders.
- Other names
- TRIM41RINCKE3 ubiquitin-protein ligase TRIM41
02
Mechanism of action
Drugs or interventions that enhance TRIM41 activity could theoretically boost innate antiviral responses by increasing ubiquitination and degradation of viral proteins. Modulation of TRIM41's E3 ligase function could regulate antiviral defense and meiosis, offering possibilities for therapy in viral infections or infertility, though no specific drug mechanisms are established.
03
Biological functions
Innate antiviral response via polyubiquitination of viral nucleoproteinsUbiquitination and protein degradation (E3 ligase activity)Regulation of chromosome axis protein dynamics during meiosisPossible involvement in protein kinase C signaling
04
Disease associations
Infection (host restriction of viral infections such as influenza A and vesicular stomatitis virus)Possible role in male infertility (deficiency impairs meiotic progression)Immune response regulation, including connections to inflammation and autoimmunity
05
Safety considerations
Enhancing TRIM41 activity could potentially exacerbate inflammation or autoimmunity due to its role in cytokine production and interferon responseModulation of meiosis through TRIM41 could carry risks related to fertilityNo drug-specific safety concerns are described due to lack of TRIM41-targeting inhibitors or agonists in clinical use.
06
Biomarkers
Reduced TRIM41 expression or function could serve as a biomarker for increased susceptibility to viral infections or meiotic defectsTRIM41 protein levels/activity in immune cells or germ cells may be of biomarker interest but are not yet clinically validated
Beyond the preview
Go deeper on Tripartite motif containing 41 (TRIM41).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tripartite motif containing 41 (TRIM41).